financetom
Business
financetom
/
Business
/
COPT Defense Prices $400 Million Senior Notes Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
COPT Defense Prices $400 Million Senior Notes Offering
Sep 23, 2025 3:11 PM

05:30 PM EDT, 09/23/2025 (MT Newswires) -- COPT Defense Properties ( CDP ) said late Tuesday an operating partnership has priced an underwritten public offering of $400 million of 4.500% senior notes due 2030.

The company said the partnership plans to use the proceeds for general corporate purposes. It expects to close the offering Oct. 2.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Marriott International Insider Sold Shares Worth $563,476, According to a Recent SEC Filing
Marriott International Insider Sold Shares Worth $563,476, According to a Recent SEC Filing
Dec 9, 2024
05:37 PM EST, 12/09/2024 (MT Newswires) -- Satyajit Anand, President, EMEA, on December 06, 2024, sold 1,919 shares in Marriott International ( MAR ) for $563,476. Following the Form 4 filing with the SEC, Anand has control over a total of 27,833 shares of the company, with 27,833 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1048286/000122520824010650/xslF345X05/doc4.xml ...
Fate Therapeutics Reports FT819 Shows 'Favorable Safety Profile,' Clinical Benefits
Fate Therapeutics Reports FT819 Shows 'Favorable Safety Profile,' Clinical Benefits
Dec 9, 2024
05:41 PM EST, 12/09/2024 (MT Newswires) -- Fate Therapeutics ( FATE ) said new data from FT819's phase 1 study in patients with moderate to severe systemic lupus erythematosus showed no dose-limiting toxicities in the first three patients. The drug showed rapid, deep and sustained depletion of CD19+ B cells in the periphery and a favorable safety profile, the company...
Cumberland Pharmaceuticals Gets FDA's Supplemental NDA Approval for Acetadote; Shares Soar After Hours
Cumberland Pharmaceuticals Gets FDA's Supplemental NDA Approval for Acetadote; Shares Soar After Hours
Dec 9, 2024
05:37 PM EST, 12/09/2024 (MT Newswires) -- Cumberland Pharmaceuticals ( CPIX ) said the US Food and Drug Administration approved a supplemental new drug application for acetadote, simplifying the administration of the dosing regimen. Acetadote is an intravenous formulation of N-acetylcysteine indicated to prevent or lessen liver injury after ingestion of potentially toxic quantities of acetaminophen, the company said late...
US sanctions targets include former SriLankan Airlines CEO over Airbus deal
US sanctions targets include former SriLankan Airlines CEO over Airbus deal
Dec 9, 2024
WASHINGTON (Reuters) - The U.S. State Department announced a slew of sanctions on Monday to mark International Anti-Corruption Day and the eve of Human Rights Day, targeting individuals from multiple countries, including the former CEO of SriLankan Airlines over Airbus purchases. Also targeted were North Macedonia's former deputy prime minister, Artan Grubi, as well as Enver Bexheti, a judge from that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved